GlassScriptPhysician profile
Kyle Y Oroku
NPI 1558591156
$4,033.37
in general payments reported to CMS, 2019-2025
14 companies · $707 in 2025
The $707 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.83 · 2020: $50.36 · 2021: $432 · 2022: $848 · 2023: $1,173 · 2024: $793 · 2025: $707.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,544 · Entertainment: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,543.53 |
| Entertainment | $129.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,148.70 | 2022-2025 | Infuse, Biotrue One Day, Miebo |
| Alcon Vision LLC | $813.78 | 2021-2025 | Total30, Clareon Panoptix Pro |
| Johnson & Johnson Vision Care, INC. | $619.79 | 2021-2025 | Acuvue |
| Abbvie INC. | $360.69 | 2022-2023 | |
| Coopervision INC. | $349.94 | 2021-2024 | Myday Contact Lens |
| Lkc Technologies, INC. | $260.32 | 2023-2024 | |
| Glaukos Corporation | $179.62 | 2025 | Photrexa Viscous and Photrexa |
| Optos, INC. | $129.18 | 2023-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $37.27 | 2019-2020 | |
| Aerie Pharmaceuticals, INC. | $33.73 | 2019-2021 | |
| Viiv Healthcare Company | $32.95 | 2022 | |
| Allergan, INC. | $28.66 | 2020 | |
| Novartis Pharmaceuticals Corporation | $22.51 | 2022 | |
| Sun Pharmaceutical Industries INC. | $16.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Oroku listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.